Albemarle (ALB) Financials

$59.34 +0.10 (+0.17%)

As of 03:58 PM Eastern

Annual Income Statements for Albemarle

This table shows Albemarle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-1,316	1,573	2,690	124	376	533	694	55	644	335
Consolidated Net Income / (Loss)	-1,135	1,671	2,815	200	447	604	739	99	681	360
Net Income / (Loss) Continuing Operations	-1,135	1,671	2,815	200	447	604	739	99	479	328
Total Pre-Tax Income	-1,764	247	2,433	134	374	563	795	447	515	311
Total Operating Income	-1,777	252	2,470	798	506	666	701	572	479	345
Total Gross Profit	63	1,186	3,075	998	995	1,258	1,217	1,106	970	860
Total Revenue	5,378	9,617	7,320	3,328	3,129	3,589	3,375	3,072	2,677	2,826
Operating Revenue	5,378	9,617	7,320	3,328	3,129	3,589	3,375	3,072	2,677	2,826
Total Cost of Revenue	5,315	8,431	4,246	2,330	2,134	2,332	2,158	1,966	1,707	1,966
Operating Cost of Revenue	5,315	8,431	4,246	2,330	2,134	2,332	2,158	1,966	1,707	1,966
Total Operating Expenses	1,839	1,005	596	200	489	592	516	535	492	515
Selling, General & Admin Expense	618	910	524	441	430	533	446	450	354	300
Research & Development Expense	87	86	72	54	59	58	70	84	80	89
Restructuring Charge	1,134	9.49	0.00	-	-	-	-	-	57	125
Total Other Income / (Expense), net	13	66	-45	-665	-132	-103	94	-125	37	-34
Interest Expense	166	116	123	61	73	58	52	115	65	82
Other Income / (Expense), net	178	182	78	-603	-59	-45	146	-9.51	102	47
Income Tax Expense	87	430	391	29	54	88	145	432	96	11
Other Gains / (Losses), net	715	1,854	772	96	128	130	89	84	60	28
Preferred Stock Dividends Declared	137	0.00	0.00	-	-	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	44	97	125	76	71	71	46	45	37	25
Basic Earnings per Share	($11.20)	$13.41	$22.97	$1.07	$3.53	$5.03	$6.40	$0.49	$5.73	$3.01
Weighted Average Basic Shares Outstanding	117.52M	117.32M	117.12M	115.84M	106.40M	105.95M	108.43M	110.91M	112.38M	111.18M
Diluted Earnings per Share	($11.20)	$13.36	$22.84	$1.06	$3.52	$5.02	$6.34	$0.49	$5.68	$3.00
Weighted Average Diluted Shares Outstanding	117.52M	117.77M	117.79M	116.54M	106.81M	106.32M	109.46M	112.38M	113.24M	111.56M
Weighted Average Basic & Diluted Shares Outstanding	117.57M	117.40M	-	117.20M	116.63M	106.21M	108.40M	111.90M	112.57M	112.25M
Cash Dividends to Common per Share	$1.61	$1.60	$1.58	$1.56	$1.54	$1.47	$1.34	$1.28	$1.22	$1.16

This table shows Albemarle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-0.34	34	-1,111	-230	-9.14	-618	303	650	1,239	1,132	897
Consolidated Net Income / (Loss)	49	85	-1,061	-177	17	-603	321	676	1,277	1,162	931
Net Income / (Loss) Continuing Operations	49	85	-1,061	-177	17	-603	321	676	1,277	1,162	931
Total Pre-Tax Income	-19	77	-1,179	-494	-168	-921	-158	168	1,157	863	869
Total Operating Income	20	4.40	-1,109	-493	-180	-850	-140	140	1,102	825	891
Total Gross Profit	156	138	-104	-11	39	-704	55	558	1,277	1,001	1,044
Total Revenue	1,077	1,232	1,355	1,430	1,361	2,356	2,311	2,370	2,580	2,621	2,092
Operating Revenue	1,077	1,232	1,355	1,430	1,361	2,356	2,311	2,370	2,580	2,621	2,092
Total Cost of Revenue	921	1,094	1,459	1,441	1,322	3,060	2,256	1,812	1,304	1,620	1,048
Operating Cost of Revenue	921	1,094	1,459	1,441	1,322	3,060	2,256	1,812	1,304	1,620	1,048
Total Operating Expenses	137	134	1,005	482	218	217	195	418	175	168	153
Selling, General & Admin Expense	124	100	154	169	195	187	172	397	154	148	134
Research & Development Expense	14	20	22	21	24	23	21	21	20	20	18
Restructuring Charge	-1.06	-	828	-	-	-	1.76	-	-	-	-
Total Other Income / (Expense), net	-39	72	-70	-1.52	12	0.11	-18	28	56	30	-22
Interest Expense	49	45	48	35	38	34	29	26	27	24	30
Other Income / (Expense), net	10	117	-22	34	50	34	11	54	82	54	7.97
Income Tax Expense	-3.98	11	111	-31	-3.72	119	-8.55	43	277	24	197
Other Gains / (Losses), net	64	19	229	287	181	437	470	551	396	323	259
Preferred Stock Dividends Declared	42	42	42	42	12	-	0.00	0.00	0.00	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	7.95	9.82	8.35	12	14	14	18	26	38	29	34
Basic Earnings per Share	$0.00	$0.29	($9.45)	($1.96)	($0.08)	($5.28)	$2.58	$5.54	$10.57	$9.68	$7.66
Weighted Average Basic Shares Outstanding	117.60M	117.52M	117.54M	117.53M	117.45M	117.32M	117.35M	117.33M	117.23M	117.12M	117.14M
Diluted Earnings per Share	$0.00	$0.29	($9.45)	($1.96)	($0.08)	($5.24)	$2.57	$5.52	$10.51	$9.62	$7.61
Weighted Average Diluted Shares Outstanding	117.60M	117.52M	117.54M	117.53M	117.45M	117.77M	117.78M	117.77M	117.84M	117.79M	117.87M
Weighted Average Basic & Diluted Shares Outstanding	117.66M	117.57M	117.54M	117.53M	117.53M	117.40M	117.35M	117.35M	117.34M	0.00	117.15M
Cash Dividends to Common per Share	$0.41	-	$0.41	$0.40	$0.40	-	$0.40	$0.40	$0.40	-	$0.40

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	302	-609	1,060	-307	134	58	-544	-1,132	2,056	-2,276
Net Cash From Operating Activities	702	1,325	1,908	344	799	719	546	304	736	361
Net Cash From Continuing Operating Activities	702	1,325	1,908	344	799	719	546	304	736	361
Net Income / (Loss) Continuing Operations	-1,135	1,671	2,815	200	447	604	739	99	681	360
Consolidated Net Income / (Loss)	-1,135	1,671	2,815	200	447	604	739	99	681	360
Depreciation Expense	589	430	301	254	232	213	201	197	226	260
Non-Cash Adjustments To Reconcile Net Income	121	639	113	-183	209	1.48	-291	172	-432	-81
Changes in Operating Assets and Liabilities, net	1,128	-1,414	-1,321	73	-89	-100	-103	-165	260	-178
Net Cash From Investing Activities	-1,574	-2,781	-1,423	-667	-864	-1,664	-304	-358	2,920	-2,161
Net Cash From Continuing Investing Activities	-1,574	-2,781	-1,423	-667	-864	-1,664	-304	-358	2,920	-2,161
Purchase of Property, Plant & Equipment	-1,686	-2,149	-1,262	-954	-850	-852	-700	-318	-197	-228
Acquisitions	0.00	-426	-162	0.00	-23	-820	-11	-44	-209	-2,100
Purchase of Investments	-0.27	-1.20	-0.71	-6.49	-2.43	-2.57	-5.87	-3.84	0.00	1.00
Sale of Property, Plant & Equipment	29	0.00	0.00	-	-	10	0.00	0.00	-	-
Sale and/or Maturity of Investments	83	-204	1.94	3.77	0.90	0.38	-	-	0.31	98
Net Cash From Financing Activities	1,242	624	612	50	177	1,043	-787	-1,087	-1,580	-478
Net Cash From Continuing Financing Activities	1,242	624	612	50	177	1,043	-787	-1,087	-1,580	-478
Repayment of Debt	-747	588	-1,113	-1,140	-116	-314	-114	-825	-1,416	-2,580
Payment of Dividends	-348	-293	-229	-274	-194	-235	-159	-177	-171	-143
Issuance of Debt	112	356	1,964	0.00	452	1,598	0.00	166	0.00	2,250
Issuance of Preferred Equity	2,237	0.00	0.00	-	-	-	-	-	-	-
Other Financing Activities, net	-12	-27	-11	10	35	-6.22	-14	-0.14	7.21	-1.03
Effect of Exchange Rate Changes	-67	223	-37	-35	21	-41	-	8.24	-20	2.15

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	326	-472	-166	-226	1,166	-712	1.93	13	88	116	452
Net Cash From Operating Activities	545	0.67	241	363	98	-98	629	74	721	952	895
Net Cash From Continuing Operating Activities	545	0.67	241	363	98	-98	629	74	721	952	895
Net Income / (Loss) Continuing Operations	49	85	-1,061	-177	17	-603	321	676	1,277	1,162	931
Consolidated Net Income / (Loss)	49	85	-1,061	-177	17	-603	321	676	1,277	1,162	931
Depreciation Expense	162	163	164	138	124	144	105	93	87	86	78
Non-Cash Adjustments To Reconcile Net Income	362	-665	759	133	-107	261	417	-146	107	100	-36
Changes in Operating Assets and Liabilities, net	-28	417	379	268	64	100	-215	-550	-750	-395	-78
Net Cash From Investing Activities	-179	-328	-302	-450	-495	-1,066	-663	-514	-539	-609	-313
Net Cash From Continuing Investing Activities	-179	-328	-302	-450	-495	-1,066	-663	-514	-539	-609	-313
Purchase of Property, Plant & Equipment	-183	-356	-303	-448	-579	-684	-546	-504	-416	-446	-313
Purchase of Investments	-0.06	-0.05	-83	83	-0.07	0.08	-0.09	-0.06	-1.13	-0.20	0.26
Sale and/or Maturity of Investments	3.38	-1.13	-	-	85	1.50	-82	-1.71	-122	-1.19	-0.27
Net Cash From Financing Activities	-120	-93	-110	-113	1,557	397	100	246	-119	-299	-65
Net Cash From Continuing Financing Activities	-120	-93	-110	-113	1,557	397	100	246	-119	-299	-65
Repayment of Debt	-11	-31	-30	-36	-651	415	174	-0.79	-0.71	-253	-0.49
Payment of Dividends	-107	-89	-108	-105	-47	-73	-73	-47	-99	-46	-64
Issuance of Debt	0.00	28	28	27	29	56	-	300	0.00	-	-
Issuance of Preferred Equity	0.00	-	-	-	2,237	-	-	-	0.00	-	-
Other Financing Activities, net	-1.72	-0.74	-0.19	-0.06	-11	-1.23	-1.22	-6.29	-19	0.01	-0.83
Effect of Exchange Rate Changes	80	-52	5.83	-	-	55	-	-	24	73	-64

This table presents Albemarle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2022	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	16,610	18,271	15,457	15,457	10,451	9,861	7,582	7,751	8,161	9,598
Total Current Assets	3,842	5,217	5,187	5,187	2,206	2,225	1,998	2,478	3,307	1,831
Cash & Equivalents	1,192	890	1,499	1,499	747	613	555	1,137	2,270	214
Accounts Receivable	981	1,722	1,377	1,377	593	680	658	572	528	473
Inventories, net	1,503	2,161	2,076	2,076	750	769	701	593	450	440
Other Current Assets	167	443	235	235	116	163	85	136	59	63
Plant, Property, & Equipment, net	9,331	9,495	6,963	6,963	5,355	4,909	3,021	2,493	2,360	2,321
Plant, Property & Equipment, gross	12,523	12,234	9,354	9,354	7,428	6,818	4,799	4,124	3,911	3,700
Accumulated Depreciation	3,192	2,739	2,391	2,391	2,073	1,908	1,778	1,631	1,550	1,379
Total Noncurrent Assets	3,436	3,559	3,307	3,307	2,890	2,726	2,562	2,780	2,494	5,446
Long-Term Investments	1,118	1,370	1,151	1,151	656	580	529	534	458	436
Goodwill	1,583	1,630	1,618	1,618	1,666	1,579	1,567	1,610	1,540	1,461
Intangible Assets	231	262	288	288	349	355	386	422	355	384
Other Noncurrent Operating Assets	505	297	251	251	219	213	80	74	142	194
Total Liabilities & Shareholders' Equity	16,610	18,271	15,457	15,457	10,451	9,861	7,582	7,751	8,161	9,598
Total Liabilities	6,410	8,606	7,266	7,266	5,982	5,767	3,823	3,933	4,219	6,197
Total Current Liabilities	1,966	3,560	2,741	2,741	1,802	1,409	1,183	1,201	1,140	1,617
Short-Term Debt	398	626	2.13	2.13	805	187	307	422	248	675
Accounts Payable	944	2,088	2,052	2,052	483	574	523	419	282	240
Accrued Expenses	468	545	506	506	441	576	257	268	322	313
Dividends Payable	61	47	46	46	41	39	35	35	34	32
Current Deferred & Payable Income Tax Liabilities	95	255	135	135	32	32	61	55	254	27
Total Noncurrent Liabilities	4,443	5,045	4,525	4,525	4,181	4,358	2,639	2,732	3,079	4,580
Long-Term Debt	3,118	3,541	3,215	3,215	2,767	2,863	1,398	1,415	2,122	3,142
Noncurrent Deferred & Payable Income Tax Liabilities	358	558	481	481	395	398	383	370	413	385
Noncurrent Employee Benefit Liabilities	148	177	192	192	389	343	332	347	349	350
Other Noncurrent Operating Liabilities	819	769	637	637	629	755	527	599	195	239
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10,200	9,665	8,191	8,191	4,469	4,094	3,759	3,818	3,943	3,401
Total Preferred & Common Equity	9,962	9,412	7,983	7,983	4,268	3,932	3,585	3,675	3,795	3,254
Preferred Stock	2,235	0.00	-	-	-	-	-	-	-	-
Total Common Equity	7,726	9,412	7,983	7,983	4,268	3,932	3,585	3,675	3,795	3,254
Common Stock	2,987	2,954	2,942	2,942	1,439	1,385	1,370	1,865	2,086	2,060
Retained Earnings	5,482	6,987	5,601	5,601	3,155	2,943	2,566	2,035	2,122	1,615
Accumulated Other Comprehensive Income / (Loss)	-742	-529	-561	-561	-326	-396	-351	-226	-412	-421
Noncontrolling Interest	238	253	208	208	200	161	174	143	148	147

This table presents Albemarle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	16,999	16,610	17,455	18,388	19,032	18,271	18,883	19,110	17,564	15,457	13,829
Total Current Assets	4,107	3,842	4,670	5,226	5,823	5,217	7,126	7,455	6,658	5,187	4,297
Cash & Equivalents	1,519	1,192	1,665	1,830	2,056	890	1,602	1,600	1,587	1,499	1,383
Accounts Receivable	808	981	1,018	1,198	1,313	1,722	1,708	1,771	1,664	1,377	1,171
Inventories, net	1,656	1,503	1,658	1,800	1,905	2,161	3,404	3,659	3,181	2,076	1,614
Other Current Assets	125	167	329	398	550	443	412	425	226	235	129
Plant, Property, & Equipment, net	9,303	9,331	9,258	9,837	9,756	9,495	8,309	7,855	7,353	6,963	6,425
Plant, Property & Equipment, gross	12,660	12,523	12,376	12,789	12,588	12,234	10,929	10,397	9,830	9,354	8,714
Accumulated Depreciation	3,357	3,192	3,118	2,952	2,832	2,739	2,621	2,542	2,477	2,391	2,289
Total Noncurrent Assets	3,589	3,436	3,527	3,326	3,454	3,559	3,449	3,800	3,553	3,307	3,106
Long-Term Investments	1,125	1,118	1,180	1,161	1,259	1,370	1,254	1,621	1,391	1,151	1,159
Goodwill	1,606	1,583	1,638	1,601	1,614	1,630	1,606	1,635	1,634	1,618	1,468
Intangible Assets	230	231	246	243	252	262	261	274	285	288	263
Other Noncurrent Operating Assets	628	505	464	321	329	297	329	270	243	251	217
Total Liabilities & Shareholders' Equity	16,999	16,610	17,455	18,388	19,032	18,271	18,883	19,110	17,564	15,457	13,829
Total Liabilities	6,725	6,410	6,965	6,905	7,233	8,606	8,721	9,022	8,105	7,266	6,864
Total Current Liabilities	1,944	1,966	1,911	1,958	2,051	3,560	3,942	4,292	3,505	2,741	2,488
Short-Term Debt	410	398	3.01	3.21	5.08	626	162	6.25	2.17	2.13	251
Accounts Payable	918	944	1,223	1,323	1,296	2,088	2,607	3,052	2,771	2,052	1,652
Accrued Expenses	380	468	513	508	455	545	689	673	403	506	385
Dividends Payable	61	61	61	61	58	47	47	47	47	46	46
Current Deferred & Payable Income Tax Liabilities	175	95	111	63	237	255	436	513	282	135	153
Total Noncurrent Liabilities	4,781	4,443	5,054	4,947	5,182	5,045	4,779	4,730	4,600	4,525	4,376
Long-Term Debt	3,129	3,118	3,566	3,520	3,519	3,541	3,496	3,509	3,233	3,215	3,119
Noncurrent Deferred & Payable Income Tax Liabilities	378	358	526	501	657	558	290	328	486	481	429
Noncurrent Employee Benefit Liabilities	148	148	170	168	171	177	187	192	193	192	230
Other Noncurrent Operating Liabilities	1,126	819	792	758	834	769	807	701	687	637	598
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10,274	10,200	10,491	11,483	11,800	9,665	10,162	10,088	9,459	8,191	6,965
Total Preferred & Common Equity	10,028	9,962	10,241	11,223	11,533	9,412	9,898	9,815	9,213	7,983	6,733
Preferred Stock	2,235	2,235	2,235	2,235	2,235	0.00	-	-	-	-	-
Total Common Equity	7,793	7,726	8,005	8,987	9,297	9,412	9,898	9,815	9,213	7,983	6,733
Common Stock	2,993	2,987	2,980	2,971	2,964	2,954	2,947	2,937	2,933	2,942	2,935
Retained Earnings	5,434	5,482	5,496	6,654	6,931	6,987	7,652	7,396	6,793	5,601	4,515
Accumulated Other Comprehensive Income / (Loss)	-633	-742	-470	-638	-597	-529	-701	-518	-513	-561	-717
Noncontrolling Interest	246	238	250	261	267	253	265	273	246	208	232

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-44.08%	31.38%	119.96%	6.36%	-12.83%	6.36%	9.86%	14.75%	-5.28%	15.57%
EBITDA Growth	-216.86%	-69.67%	534.36%	-33.82%	-18.64%	-20.39%	38.04%	-5.89%	23.62%	82.20%
EBIT Growth	-468.25%	-82.97%	1,206.05%	-56.32%	-28.04%	-26.73%	50.69%	-3.15%	47.92%	54.16%
NOPAT Growth	-563.72%	-109.04%	233.12%	44.06%	-23.09%	-2.01%	2,891.20%	-95.08%	16.98%	34.29%
Net Income Growth	-167.97%	-40.66%	1,307.97%	-55.23%	-26.10%	-18.24%	643.09%	-85.39%	89.07%	123.77%
EPS Growth	-183.83%	-41.51%	2,054.72%	-69.89%	-29.88%	-20.82%	1,193.88%	-91.37%	89.33%	77.51%
Operating Cash Flow Growth	-47.03%	-30.53%	454.19%	-56.91%	11.06%	31.71%	79.67%	-58.67%	103.85%	-26.76%
Free Cash Flow Firm Growth	63.62%	-244.76%	237.94%	-485.31%	74.63%	-289,677.35%	100.17%	-137.04%	132.71%	-364.37%
Invested Capital Growth	-1.30%	31.97%	0.00%	31.83%	11.50%	35.65%	14.91%	6.18%	-4.32%	114.83%
Revenue Q/Q Growth	-17.29%	-2.68%	30.87%	0.45%	-3.50%	2.01%	1.93%	5.54%	6.62%	-2.35%
EBITDA Q/Q Growth	50.43%	-65.55%	46.09%	-12.45%	-3.98%	-4.03%	-1.76%	10.65%	-7.05%	46.72%
EBIT Q/Q Growth	38.68%	-79.69%	52.89%	-26.50%	-6.90%	-6.28%	-1.87%	14.19%	-8.10%	79.10%
NOPAT Q/Q Growth	32.47%	-111.65%	69.97%	-33.29%	-2.50%	37.74%	73.98%	-95.15%	-19.68%	108.47%
Net Income Q/Q Growth	37.74%	-51.38%	69.20%	-31.44%	-0.90%	-6.18%	91.48%	-89.15%	168.87%	120.47%
EPS Q/Q Growth	33.05%	-52.66%	73.29%	-43.92%	-1.68%	-7.04%	100.00%	-93.67%	194.30%	147.93%
Operating Cash Flow Q/Q Growth	16.40%	-44.22%	135.75%	-58.41%	-4.37%	39.72%	-9.89%	-14.67%	47.69%	-4.79%
Free Cash Flow Firm Q/Q Growth	48.17%	-91.90%	1,445.26%	-240.15%	75.82%	-125.68%	-99.91%	29.24%	-83.47%	62.40%
Invested Capital Q/Q Growth	1.69%	5.51%	12.31%	36.18%	1.12%	17.46%	4.06%	-10.40%	0.40%	-41.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	1.16%	12.33%	42.00%	29.99%	31.80%	35.04%	36.07%	36.01%	36.24%	30.44%
EBITDA Margin	-18.77%	8.98%	38.92%	13.49%	21.69%	23.24%	31.05%	24.71%	30.13%	23.08%
Operating Margin	-33.04%	2.62%	33.74%	23.99%	16.17%	18.56%	20.77%	18.61%	17.88%	12.21%
EBIT Margin	-29.72%	4.51%	34.81%	5.86%	14.27%	17.29%	25.10%	18.30%	21.68%	13.88%
Profit (Net Income) Margin	-21.12%	17.37%	38.46%	6.01%	14.27%	16.84%	21.90%	3.24%	25.43%	12.74%
Tax Burden Percent	64.38%	677.05%	115.69%	149.64%	119.57%	107.36%	93.01%	22.26%	132.12%	115.87%
Interest Burden Percent	110.36%	56.85%	95.50%	68.49%	83.63%	90.70%	93.81%	79.48%	88.77%	79.19%
Effective Tax Rate	0.00%	174.39%	16.05%	22.04%	14.57%	15.66%	18.22%	96.65%	18.68%	3.58%
Return on Invested Capital (ROIC)	-10.77%	-1.83%	23.55%	8.04%	6.82%	10.80%	13.89%	0.51%	10.52%	12.01%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.06%	142.91%	144.42%	-21.89%	7.53%	14.13%	62.57%	-53.17%	1,039.88%	20.38%
Return on Net Nonoperating Assets (RNNOA)	-0.66%	20.55%	12.66%	-4.88%	3.61%	4.59%	5.62%	2.05%	8.02%	2.72%
Return on Equity (ROE)	-11.43%	18.71%	36.21%	3.16%	10.43%	15.39%	19.51%	2.56%	18.54%	14.73%
Cash Return on Invested Capital (CROIC)	-9.46%	-29.40%	23.55%	-19.42%	-4.05%	-19.46%	0.01%	-5.48%	14.93%	-60.94%
Operating Return on Assets (OROA)	-9.16%	2.57%	19.28%	1.51%	4.40%	7.12%	11.05%	7.07%	6.54%	5.30%
Return on Assets (ROA)	-6.51%	9.91%	21.30%	1.54%	4.40%	6.93%	9.64%	1.25%	7.67%	4.86%
Return on Common Equity (ROCE)	-9.86%	18.23%	35.21%	3.06%	9.99%	14.74%	18.69%	2.47%	17.80%	13.90%
Return on Equity Simple (ROE_SIMPLE)	-11.40%	17.75%	35.27%	2.50%	10.46%	15.37%	20.62%	2.71%	17.94%	11.06%
Net Operating Profit after Tax (NOPAT)	-1,244	-187	2,074	622	432	562	573	19	389	333
NOPAT Margin	-23.13%	-1.95%	28.33%	18.70%	13.81%	15.65%	16.99%	0.62%	14.54%	11.77%
Net Nonoperating Expense Percent (NNEP)	-6.71%	-144.74%	-120.87%	29.93%	-0.71%	-3.33%	-48.69%	53.68%	-1,029.36%	-8.38%
Return On Investment Capital (ROIC_SIMPLE)	-9.07%	-1.35%	18.18%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	98.84%	87.67%	58.00%	70.01%	68.20%	64.96%	63.93%	63.99%	63.76%	69.56%
SG&A Expenses to Revenue	11.49%	9.46%	7.16%	13.27%	13.74%	14.86%	13.22%	14.66%	13.21%	10.63%
R&D to Revenue	1.61%	0.89%	0.98%	1.62%	1.89%	1.62%	2.08%	2.75%	3.01%	3.16%
Operating Expenses to Revenue	34.20%	10.45%	8.14%	6.00%	15.63%	16.48%	15.29%	17.40%	18.36%	18.23%
Earnings before Interest and Taxes (EBIT)	-1,598	434	2,548	195	447	621	847	562	580	392
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1,010	864	2,849	449	679	834	1,048	759	807	652
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.31	1.77	3.11	3.35	3.57	1.88	2.13	3.55	2.33	1.73
Price to Tangible Book Value (P/TBV)	1.71	2.22	4.08	4.40	6.76	3.70	4.69	7.93	4.65	4.00
Price to Revenue (P/Rev)	1.88	1.74	3.39	8.04	4.87	2.06	2.27	4.24	3.30	2.00
Price to Earnings (P/E)	0.00	10.61	9.22	216.29	40.55	13.86	11.03	237.54	13.72	16.84
Dividend Yield	1.87%	1.12%	0.75%	0.68%	1.08%	2.11%	1.86%	1.09%	1.55%	2.31%
Earnings Yield	0.00%	9.42%	10.85%	0.46%	2.47%	7.22%	9.06%	0.42%	7.29%	5.94%
Enterprise Value to Invested Capital (EV/IC)	1.20	1.62	2.91	3.13	2.64	1.57	1.91	3.47	2.38	2.37
Enterprise Value to Revenue (EV/Rev)	2.57	1.96	3.49	8.27	5.63	2.62	2.50	4.34	3.22	3.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	21.83	8.98	61.29	25.95	11.28	8.06	17.57	10.69	13.72
Enterprise Value to EBIT (EV/EBIT)	0.00	43.45	10.04	141.08	39.42	15.16	9.97	23.73	14.85	22.82
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	12.33	44.22	40.75	16.75	14.73	695.88	22.14	26.91
Enterprise Value to Operating Cash Flow (EV/OCF)	19.65	14.23	13.41	79.95	22.04	13.08	15.47	43.88	11.72	24.82
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	12.33	0.00	0.00	0.00	24,163.36	0.00	15.60	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.34	0.43	0.39	0.39	0.80	0.75	0.45	0.48	0.60	1.12
Long-Term Debt to Equity	0.31	0.37	0.39	0.39	0.62	0.70	0.37	0.37	0.54	0.92
Financial Leverage	0.16	0.14	0.09	0.22	0.48	0.33	0.09	-0.04	0.01	0.13
Leverage Ratio	1.76	1.89	1.89	2.05	2.37	2.22	2.02	2.05	2.42	3.03
Compound Leverage Factor	1.94	1.07	1.80	1.40	1.98	2.01	1.90	1.63	2.15	2.40
Debt to Total Capital	25.64%	30.12%	28.20%	28.20%	44.43%	42.70%	31.21%	32.49%	37.54%	52.88%
Short-Term Debt to Total Capital	2.90%	4.52%	0.02%	0.02%	10.01%	2.62%	5.62%	7.46%	3.92%	9.35%
Long-Term Debt to Total Capital	22.73%	25.60%	28.18%	28.18%	34.42%	40.08%	25.58%	25.03%	33.61%	43.53%
Preferred Equity to Total Capital	16.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.74%	1.83%	1.83%	1.83%	2.49%	2.26%	3.18%	2.53%	2.34%	2.04%
Common Equity to Total Capital	56.33%	68.05%	69.97%	69.97%	53.08%	55.04%	65.61%	64.98%	60.13%	45.08%
Debt to EBITDA	-3.48	4.82	1.13	7.16	5.26	3.66	1.63	2.42	2.94	5.85
Net Debt to EBITDA	-1.19	2.21	0.20	1.26	3.20	2.23	0.59	0.22	-0.44	4.86
Long-Term Debt to EBITDA	-3.09	4.10	1.13	7.16	4.08	3.43	1.33	1.86	2.63	4.82
Debt to NOPAT	-2.83	-22.24	1.55	5.17	8.27	5.43	2.97	95.86	6.09	11.47
Net Debt to NOPAT	-0.97	-10.18	0.27	0.91	5.02	3.31	1.08	8.66	-0.92	9.52
Long-Term Debt to NOPAT	-2.51	-18.90	1.55	5.16	6.40	5.10	2.44	73.84	5.45	9.44
Altman Z-Score	1.55	2.41	3.76	3.16	2.44	1.86	2.62	3.19	2.50	1.24
Noncontrolling Interest Sharing Ratio	13.72%	2.58%	2.78%	3.23%	4.22%	4.27%	4.18%	3.75%	4.01%	5.65%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.95	1.47	1.89	1.89	1.22	1.58	1.69	2.06	2.90	1.13
Quick Ratio	1.10	0.73	1.05	1.05	0.74	0.92	1.03	1.42	2.45	0.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,092	-3,002	2,074	-1,503	-257	-1,012	0.35	-205	552	-1,689
Operating Cash Flow to CapEx	42.38%	61.66%	151.22%	36.10%	93.94%	85.49%	78.02%	95.68%	374.02%	158.49%
Free Cash Flow to Firm to Interest Expense	-6.59	-25.86	16.86	-24.45	-3.51	-17.55	0.01	-1.77	8.48	-20.68
Operating Cash Flow to Interest Expense	4.24	11.42	15.51	5.60	10.93	12.47	10.42	2.64	11.28	4.42
Operating Cash Flow Less CapEx to Interest Expense	-5.76	-7.10	5.25	-9.91	-0.71	-2.12	-2.94	-0.12	8.27	1.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.31	0.57	0.55	0.26	0.31	0.41	0.44	0.39	0.30	0.38
Accounts Receivable Turnover	3.98	6.21	7.32	3.38	4.92	5.37	5.49	5.58	5.35	6.23
Inventory Turnover	2.90	3.98	2.95	1.65	2.81	3.17	3.34	3.77	3.84	4.93
Fixed Asset Turnover	0.57	1.17	1.14	0.54	0.61	0.91	1.22	1.27	1.14	1.59
Accounts Payable Turnover	3.51	4.07	3.14	1.84	4.04	4.25	4.59	5.61	6.55	8.34
Days Sales Outstanding (DSO)	91.73	58.81	49.86	108.01	74.25	68.03	66.51	65.37	68.23	58.60
Days Inventory Outstanding (DIO)	125.80	91.72	123.57	221.37	129.92	115.02	109.39	96.84	95.13	74.06
Days Payable Outstanding (DPO)	104.11	89.61	116.06	198.58	90.42	85.84	79.60	65.03	55.75	43.74
Cash Conversion Cycle (CCC)	113.42	60.91	57.37	130.81	113.75	97.21	96.31	97.18	107.61	88.91
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,467	11,619	8,804	8,804	6,679	5,990	4,415	3,842	3,619	3,782
Invested Capital Turnover	0.47	0.94	0.83	0.43	0.49	0.69	0.82	0.82	0.72	1.02
Increase / (Decrease) in Invested Capital	-152	2,814	0.00	2,126	689	1,574	573	224	-163	2,021
Enterprise Value (EV)	13,797	18,856	25,577	27,525	17,607	9,408	8,448	13,338	8,619	8,954
Market Capitalization	10,118	16,696	24,802	26,749	15,238	7,390	7,653	13,029	8,829	5,639
Book Value per Share	$65.73	$80.20	$68.14	$68.24	$40.09	$37.09	$33.76	$33.26	$33.74	$29.00
Tangible Book Value per Share	$50.31	$64.09	$51.87	$51.95	$21.17	$18.85	$15.37	$14.87	$16.90	$12.57
Total Capital	13,716	13,832	11,408	11,408	8,041	7,144	5,464	5,655	6,312	7,218
Total Debt	3,516	4,167	3,217	3,217	3,572	3,050	1,705	1,837	2,369	3,817
Total Long-Term Debt	3,118	3,541	3,215	3,215	2,767	2,863	1,398	1,415	2,122	3,142
Net Debt	1,206	1,907	567	567	2,169	1,857	621	166	-358	3,168
Capital Expenditures (CapEx)	1,657	2,149	1,262	954	850	841	700	318	197	228
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,082	1,392	949	949	462	390	567	561	144	676
Debt-free Net Working Capital (DFNWC)	2,274	2,282	2,448	2,448	1,209	1,003	1,123	1,699	2,414	889
Net Working Capital (NWC)	1,876	1,656	2,446	2,446	404	816	815	1,277	2,167	214
Net Nonoperating Expense (NNE)	-108	-1,858	-742	423	-15	-43	-166	-80	-292	-27
Net Nonoperating Obligations (NNO)	1,267	1,954	614	614	2,210	1,896	656	25	-324	381
Total Depreciation and Amortization (D&A)	589	430	301	254	232	213	201	197	226	260
Debt-free, Cash-free Net Working Capital to Revenue	20.11%	14.48%	12.96%	28.51%	14.77%	10.87%	16.81%	18.27%	5.39%	23.90%
Debt-free Net Working Capital to Revenue	42.28%	23.73%	33.44%	73.56%	38.64%	27.96%	33.26%	55.30%	90.17%	31.46%
Net Working Capital to Revenue	34.88%	17.22%	33.41%	73.50%	12.92%	22.74%	24.16%	41.56%	80.92%	7.58%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($11.20)	$13.41	$0.00	$0.00	$3.53	$5.03	$6.40	$0.49	$0.00	$3.01
Adjusted Weighted Average Basic Shares Outstanding	117.52M	117.32M	0.00	0.00	106.40M	105.95M	108.43M	110.91M	0.00	111.18M
Adjusted Diluted Earnings per Share	($11.20)	$13.36	$0.00	$0.00	$3.52	$5.02	$6.34	$0.49	$0.00	$3.00
Adjusted Weighted Average Diluted Shares Outstanding	117.52M	117.77M	0.00	0.00	106.81M	106.32M	109.46M	112.38M	0.00	111.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.57M	117.40M	0.00	0.00	116.63M	106.21M	105.75M	110.64M	0.00	112.25M
Normalized Net Operating Profit after Tax (NOPAT)	-450	183	2,074	622	432	562	573	400	436	454
Normalized NOPAT Margin	-8.36%	1.90%	28.33%	18.70%	13.81%	15.65%	16.99%	13.03%	16.28%	16.05%
Pre Tax Income Margin	-32.80%	2.57%	33.24%	4.02%	11.94%	15.68%	23.55%	14.54%	19.25%	10.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-9.65	3.74	20.72	3.17	6.11	10.76	16.16	4.87	8.91	4.81
NOPAT to Interest Expense	-7.51	-1.61	16.86	10.13	5.91	9.74	10.94	0.17	5.97	4.08
EBIT Less CapEx to Interest Expense	-19.65	-14.78	10.46	-12.34	-5.52	-3.83	2.81	2.12	5.89	2.02
NOPAT Less CapEx to Interest Expense	-17.51	-20.13	6.60	-5.39	-5.72	-4.85	-2.42	-2.59	2.95	1.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-30.69%	17.53%	8.12%	137.03%	43.41%	38.95%	21.56%	178.26%	25.15%	39.60%
Augmented Payout Ratio	-30.69%	17.53%	8.12%	137.03%	43.41%	38.95%	89.21%	429.60%	25.15%	40.93%

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-20.86%	-47.72%	-41.37%	-39.65%	-47.26%	-10.10%	10.46%	60.19%	128.80%	193.11%	151.85%
EBITDA Growth	3,375.79%	142.39%	-4,037.27%	-211.72%	-100.46%	-169.61%	-102.39%	-44.14%	222.68%	1,372.67%	317.23%
EBIT Growth	123.16%	114.89%	-777.95%	-336.63%	-110.94%	-192.79%	-114.33%	-56.21%	261.63%	31,984.18%	275.69%
NOPAT Growth	111.01%	100.64%	-691.94%	-430.75%	-114.99%	-174.22%	-114.22%	-69.14%	257.75%	3,760.16%	648.50%
Net Income Growth	196.14%	114.11%	-430.73%	-126.11%	-98.70%	-151.93%	-65.56%	53.53%	353.46%	10,997.39%	348.70%
EPS Growth	100.00%	105.53%	-467.70%	-135.51%	-100.76%	-154.47%	-66.23%	59.54%	388.84%	24,150.00%	326.49%
Operating Cash Flow Growth	456.77%	100.69%	-61.75%	392.34%	-86.41%	-110.31%	-29.76%	150.53%	249.69%	750.76%	754.83%
Free Cash Flow Firm Growth	134.98%	104.56%	68.16%	15.45%	-38.42%	-525.32%	-377.42%	-159.71%	-567.02%	137.32%	-395.89%
Invested Capital Growth	-6.93%	-1.30%	2.41%	15.79%	23.60%	31.97%	40.47%	30.86%	36.18%	0.00%	21.25%
Revenue Q/Q Growth	-12.57%	-9.08%	-5.29%	5.12%	-42.25%	1.97%	-2.51%	-8.14%	-1.55%	25.30%	41.38%
EBITDA Q/Q Growth	-32.60%	129.41%	-201.74%	-5,377.72%	99.21%	-2,770.11%	-108.15%	-77.43%	30.72%	-1.27%	90.07%
EBIT Q/Q Growth	-75.29%	110.74%	-146.45%	-254.11%	85.38%	-532.90%	-166.42%	-83.62%	33.49%	-2.25%	102.99%
NOPAT Q/Q Growth	264.68%	100.49%	-125.09%	-174.43%	78.88%	-506.99%	-194.01%	-87.56%	4.56%	16.32%	103.98%
Net Income Q/Q Growth	-42.08%	108.02%	-500.61%	-1,160.82%	102.76%	-288.12%	-52.59%	-47.02%	9.89%	24.76%	111.35%
EPS Q/Q Growth	-100.00%	103.07%	-382.14%	-2,350.00%	98.47%	-303.89%	-53.44%	-47.48%	9.25%	26.41%	119.94%
Operating Cash Flow Q/Q Growth	80,817.36%	-99.72%	-33.71%	270.47%	199.73%	-115.62%	753.18%	-89.78%	-24.29%	6.36%	713.78%
Free Cash Flow Firm Q/Q Growth	447.05%	114.92%	47.71%	18.05%	28.72%	-4.25%	-38.86%	-34.15%	-319.02%	217.02%	24.46%
Invested Capital Q/Q Growth	-2.06%	1.69%	-6.62%	0.07%	3.86%	5.51%	5.59%	6.82%	10.89%	12.31%	-1.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.51%	11.22%	-7.68%	-0.74%	2.86%	-29.88%	2.38%	23.56%	49.47%	38.20%	49.90%
EBITDA Margin	17.81%	23.10%	-71.42%	-22.42%	-0.43%	-28.49%	-1.01%	12.11%	49.28%	36.79%	46.69%
Operating Margin	1.84%	0.36%	-81.85%	-34.44%	-13.19%	-36.07%	-6.06%	5.91%	42.70%	31.46%	42.59%
EBIT Margin	2.79%	9.86%	-83.49%	-32.09%	-9.52%	-34.61%	-5.58%	8.18%	45.90%	33.53%	42.97%
Profit (Net Income) Margin	4.58%	6.91%	-78.29%	-12.35%	1.22%	-25.60%	13.88%	28.54%	49.48%	44.33%	44.52%
Tax Burden Percent	-259.93%	110.93%	89.97%	35.74%	-9.93%	65.51%	-202.76%	401.75%	110.30%	134.61%	107.13%
Interest Burden Percent	-63.20%	63.19%	104.22%	107.67%	129.30%	112.95%	122.77%	86.81%	97.74%	98.22%	96.70%
Effective Tax Rate	0.00%	13.83%	0.00%	0.00%	0.00%	0.00%	0.00%	25.53%	23.93%	2.79%	22.66%
Return on Invested Capital (ROIC)	0.56%	0.14%	-33.43%	-15.98%	-7.10%	-23.78%	-4.45%	4.62%	33.66%	25.43%	25.76%
ROIC Less NNEP Spread (ROIC-NNEP)	6.35%	5.19%	-68.22%	20.07%	42.62%	-24.43%	44.13%	61.56%	94.61%	84.14%	59.28%
Return on Net Nonoperating Assets (RNNOA)	0.35%	0.84%	-5.40%	0.87%	1.15%	-3.51%	4.44%	7.55%	8.79%	7.38%	6.66%
Return on Equity (ROE)	0.91%	0.99%	-38.83%	-15.11%	-5.96%	-27.29%	-0.01%	12.17%	42.44%	32.80%	32.42%
Cash Return on Invested Capital (CROIC)	-2.30%	-9.46%	-18.90%	-24.97%	-27.71%	-29.40%	-16.60%	-0.27%	0.92%	23.55%	-2.16%
Operating Return on Assets (OROA)	0.79%	3.04%	-29.88%	-12.76%	-4.37%	-19.74%	-3.37%	5.00%	27.79%	18.57%	19.49%
Return on Assets (ROA)	1.29%	2.13%	-28.02%	-4.91%	0.56%	-14.60%	8.39%	17.44%	29.96%	24.55%	20.19%
Return on Common Equity (ROCE)	0.71%	0.85%	-33.66%	-13.17%	-5.19%	-26.59%	-0.01%	11.81%	41.20%	31.89%	31.33%
Return on Equity Simple (ROE_SIMPLE)	-11.00%	0.00%	-17.81%	-3.94%	3.56%	0.00%	34.71%	41.22%	41.36%	0.00%	24.71%
Net Operating Profit after Tax (NOPAT)	14	3.79	-776	-345	-126	-595	-98	104	838	802	689
NOPAT Margin	1.28%	0.31%	-57.30%	-24.11%	-9.23%	-25.25%	-4.24%	4.40%	32.48%	30.58%	32.94%
Net Nonoperating Expense Percent (NNEP)	-5.79%	-5.05%	34.79%	-36.04%	-49.72%	0.65%	-48.57%	-56.94%	-60.96%	-58.71%	-33.51%
Return On Investment Capital (ROIC_SIMPLE)	0.10%	0.03%	-	-	-	-4.30%	-	-	-	7.03%	-
Cost of Revenue to Revenue	85.49%	88.78%	107.68%	100.74%	97.14%	129.88%	97.62%	76.44%	50.53%	61.80%	50.10%
SG&A Expenses to Revenue	11.47%	8.11%	11.39%	11.81%	14.32%	7.92%	7.45%	16.75%	5.98%	5.65%	6.43%
R&D to Revenue	1.31%	1.63%	1.65%	1.45%	1.73%	0.97%	0.91%	0.90%	0.79%	0.77%	0.88%
Operating Expenses to Revenue	12.68%	10.86%	74.17%	33.70%	16.05%	9.21%	8.44%	17.66%	6.77%	6.42%	7.31%
Earnings before Interest and Taxes (EBIT)	30	121	-1,131	-459	-130	-815	-129	194	1,184	879	899
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	192	285	-968	-321	-5.85	-671	-23	287	1,272	964	977
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.09	1.31	1.39	1.25	0.00	1.77	1.99	2.64	2.77	3.11	4.52
Price to Tangible Book Value (P/TBV)	1.42	1.71	1.82	1.57	0.00	2.22	2.45	3.27	3.50	4.08	6.09
Price to Revenue (P/Rev)	1.66	1.88	1.71	1.51	0.00	1.74	1.99	2.68	2.91	3.39	5.44
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	10.61	5.92	6.60	6.95	9.22	19.60
Dividend Yield	2.24%	1.87%	1.69%	1.68%	1.22%	1.12%	0.95%	0.72%	0.73%	0.75%	0.61%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	9.42%	16.90%	15.15%	14.38%	10.85%	5.10%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.20	1.27	1.18	0.00	1.62	1.88	2.53	2.67	2.91	4.02
Enterprise Value to Revenue (EV/Rev)	2.33	2.57	2.21	1.91	0.00	1.96	2.10	2.74	2.97	3.49	5.63
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	21.83	8.27	7.54	6.98	8.98	16.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	43.45	9.71	8.35	7.63	10.04	18.91
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	12.90	10.86	9.75	12.33	25.83
Enterprise Value to Operating Cash Flow (EV/OCF)	10.30	19.65	23.78	14.38	0.00	14.23	8.73	10.00	10.76	13.41	38.93
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	334.93	12.33	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.34	0.34	0.34	0.31	0.30	0.43	0.36	0.35	0.34	0.39	0.48
Long-Term Debt to Equity	0.30	0.31	0.34	0.31	0.30	0.37	0.34	0.35	0.34	0.39	0.45
Financial Leverage	0.06	0.16	0.08	0.04	0.03	0.14	0.10	0.12	0.09	0.09	0.11
Leverage Ratio	1.63	1.76	1.76	1.74	1.72	1.89	1.91	1.93	1.87	1.89	1.92
Compound Leverage Factor	-1.03	1.11	1.83	1.87	2.23	2.13	2.34	1.68	1.83	1.85	1.85
Debt to Total Capital	25.62%	25.64%	25.38%	23.48%	23.00%	30.12%	26.47%	25.84%	25.49%	28.20%	32.61%
Short-Term Debt to Total Capital	2.97%	2.90%	0.02%	0.02%	0.03%	4.52%	1.17%	0.05%	0.02%	0.02%	2.43%
Long-Term Debt to Total Capital	22.65%	22.73%	25.36%	23.45%	22.97%	25.60%	25.30%	25.80%	25.47%	28.18%	30.18%
Preferred Equity to Total Capital	16.18%	16.30%	15.90%	14.89%	14.59%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.78%	1.74%	1.78%	1.74%	1.74%	1.83%	1.91%	2.00%	1.94%	1.83%	2.24%
Common Equity to Total Capital	56.42%	56.33%	56.94%	59.89%	60.67%	68.05%	71.62%	72.15%	72.57%	69.97%	65.15%
Debt to EBITDA	-4.36	-3.48	-1.75	-3.23	-7.27	4.82	1.46	1.00	0.87	1.13	1.73
Net Debt to EBITDA	-1.10	-1.19	-0.36	-0.49	-0.43	2.21	0.32	0.08	0.07	0.20	0.42
Long-Term Debt to EBITDA	-3.85	-3.09	-1.75	-3.22	-7.26	4.10	1.39	1.00	0.87	1.13	1.60
Debt to NOPAT	-3.21	-2.83	-1.94	-3.03	-4.89	-22.24	2.27	1.44	1.21	1.55	2.76
Net Debt to NOPAT	-0.81	-0.97	-0.39	-0.46	-0.29	-10.18	0.50	0.12	0.10	0.27	0.68
Long-Term Debt to NOPAT	-2.83	-2.51	-1.94	-3.03	-4.88	-18.90	2.17	1.44	1.21	1.55	2.56
Altman Z-Score	1.66	1.89	1.75	2.02	0.00	2.19	2.62	3.00	3.37	3.41	3.89
Noncontrolling Interest Sharing Ratio	22.58%	13.72%	13.31%	12.83%	12.93%	2.58%	2.90%	2.98%	2.94%	2.78%	3.37%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.11	1.95	2.44	2.67	2.84	1.47	1.81	1.74	1.90	1.89	1.73
Quick Ratio	1.20	1.10	1.40	1.55	1.64	0.73	0.84	0.79	0.93	1.05	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	850	155	-1,041	-1,991	-2,430	-3,409	-3,270	-2,355	-1,756	802	-685
Operating Cash Flow to CapEx	298.64%	0.19%	79.36%	81.07%	16.91%	-14.36%	115.20%	14.63%	173.48%	213.65%	285.74%
Free Cash Flow to Firm to Interest Expense	17.36	3.48	-21.80	-56.59	-64.00	-99.15	-111.49	-92.08	-65.56	33.35	-23.07
Operating Cash Flow to Interest Expense	11.14	0.02	5.04	10.31	2.58	-2.86	21.44	2.88	26.93	39.61	30.15
Operating Cash Flow Less CapEx to Interest Expense	7.41	-7.94	-1.31	-2.41	-12.68	-22.75	2.83	-16.81	11.40	21.07	19.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.31	0.36	0.40	0.46	0.57	0.60	0.61	0.61	0.55	0.45
Accounts Receivable Turnover	4.80	3.98	4.77	5.02	5.64	6.21	6.87	6.76	7.33	7.32	6.40
Inventory Turnover	2.76	2.90	2.88	2.96	3.32	3.98	2.79	2.37	2.32	2.95	2.78
Fixed Asset Turnover	0.53	0.57	0.74	0.84	0.98	1.17	1.34	1.37	1.31	1.14	0.93
Accounts Payable Turnover	4.44	3.51	3.80	3.69	4.16	4.07	3.28	2.79	2.69	3.14	2.99
Days Sales Outstanding (DSO)	75.97	91.73	76.52	72.65	64.70	58.81	53.16	53.97	49.81	49.86	57.03
Days Inventory Outstanding (DIO)	132.26	125.80	126.87	123.32	109.85	91.72	131.01	153.84	157.17	123.57	131.17
Days Payable Outstanding (DPO)	82.21	104.11	95.99	98.85	87.84	89.61	111.19	130.78	135.52	116.06	122.16
Cash Conversion Cycle (CCC)	126.02	113.42	107.39	97.12	86.71	60.91	72.99	77.03	71.46	57.37	66.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,231	11,467	11,277	12,076	12,068	11,619	11,012	10,429	9,763	8,804	7,839
Invested Capital Turnover	0.44	0.47	0.58	0.66	0.77	0.94	1.05	1.05	1.04	0.83	0.78
Increase / (Decrease) in Invested Capital	-836	-152	265	1,647	2,304	2,814	3,172	2,459	2,594	0.00	1,374
Enterprise Value (EV)	11,845	13,797	14,342	14,254	0.00	18,856	20,737	26,434	26,057	25,577	31,508
Market Capitalization	8,468	10,118	11,132	11,226	0.00	16,696	19,670	25,866	25,553	24,802	30,447
Book Value per Share	$66.28	$65.73	$68.11	$76.47	$79.16	$80.20	$84.35	$83.65	$78.61	$68.14	$57.48
Tangible Book Value per Share	$50.67	$50.31	$52.08	$60.78	$63.28	$64.09	$68.44	$67.38	$62.24	$51.87	$42.70
Total Capital	13,813	13,716	14,060	15,006	15,324	13,832	13,821	13,604	12,695	11,408	10,335
Total Debt	3,539	3,516	3,569	3,523	3,525	4,167	3,658	3,516	3,236	3,217	3,370
Total Long-Term Debt	3,129	3,118	3,566	3,520	3,519	3,541	3,496	3,509	3,233	3,215	3,119
Net Debt	896	1,206	725	532	210	1,907	803	294	258	567	829
Capital Expenditures (CapEx)	183	356	303	448	579	684	546	504	416	446	313
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,055	1,082	1,097	1,440	1,721	1,392	1,745	1,570	1,568	949	677
Debt-free Net Working Capital (DFNWC)	2,573	2,274	2,762	3,270	3,777	2,282	3,346	3,170	3,154	2,448	2,060
Net Working Capital (NWC)	2,163	1,876	2,759	3,267	3,772	1,656	3,184	3,163	3,152	2,446	1,809
Net Nonoperating Expense (NNE)	-35	-81	284	-168	-142	8.39	-419	-572	-439	-360	-242
Net Nonoperating Obligations (NNO)	957	1,267	786	592	268	1,954	849	341	304	614	875
Total Depreciation and Amortization (D&A)	162	163	164	138	124	144	105	93	87	86	78
Debt-free, Cash-free Net Working Capital to Revenue	20.71%	20.11%	16.88%	19.31%	20.50%	14.48%	17.65%	16.24%	17.87%	12.96%	12.11%
Debt-free Net Working Capital to Revenue	50.52%	42.28%	42.48%	43.85%	44.98%	23.73%	33.86%	32.80%	35.96%	33.44%	36.83%
Net Working Capital to Revenue	42.46%	34.88%	42.43%	43.81%	44.92%	17.22%	32.22%	32.74%	35.93%	33.41%	32.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.29	($9.45)	($1.96)	($0.08)	($5.28)	$2.58	$5.54	$10.57	$9.68	$7.66
Adjusted Weighted Average Basic Shares Outstanding	117.60M	117.52M	117.54M	117.53M	117.45M	117.32M	117.35M	117.33M	117.23M	117.12M	117.14M
Adjusted Diluted Earnings per Share	$0.00	$0.29	($9.45)	($1.96)	($0.08)	($5.24)	$2.57	$5.52	$10.51	$9.62	$7.61
Adjusted Weighted Average Diluted Shares Outstanding	117.60M	117.52M	117.54M	117.53M	117.45M	117.77M	117.78M	117.77M	117.84M	117.79M	117.87M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.66M	117.57M	117.54M	117.53M	117.53M	117.40M	117.35M	117.35M	117.34M	0.00	117.15M
Normalized Net Operating Profit after Tax (NOPAT)	13	3.79	-196	-345	-126	-595	-97	104	838	802	689
Normalized NOPAT Margin	1.22%	0.31%	-14.50%	-24.11%	-9.23%	-25.25%	-4.19%	4.40%	32.48%	30.58%	32.94%
Pre Tax Income Margin	-1.76%	6.23%	-87.02%	-34.55%	-12.32%	-39.09%	-6.85%	7.10%	44.86%	32.93%	41.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.61	2.72	-23.68	-13.04	-3.41	-23.71	-4.39	7.58	44.23	36.55	30.28
NOPAT to Interest Expense	0.28	0.08	-16.25	-9.80	-3.31	-17.30	-3.34	4.08	31.30	33.35	23.21
EBIT Less CapEx to Interest Expense	-3.12	-5.24	-30.03	-25.76	-18.67	-43.61	-23.00	-12.11	28.71	18.01	19.72
NOPAT Less CapEx to Interest Expense	-3.45	-7.87	-22.60	-22.52	-18.57	-37.20	-21.95	-15.62	15.78	14.80	12.66
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-37.09%	-30.69%	-18.22%	-67.29%	58.54%	17.53%	7.74%	6.34%	7.41%	8.12%	15.80%
Augmented Payout Ratio	-37.09%	-30.69%	-18.22%	-67.29%	58.54%	17.53%	7.74%	6.34%	7.41%	8.12%	15.80%

Frequently Asked Questions About Albemarle's Financials

When does Albemarle's financial year end?

According to the most recent income statement we have on file, Albemarle's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Albemarle's net income changed over the last 9 years?

Albemarle's net income appears to be on an upward trend, with a most recent value of -$1.14 billion in 2024, falling from $360.06 million in 2015. The previous period was $1.67 billion in 2023. See where experts think Albemarle is headed by visiting Albemarle's forecast page.

What is Albemarle's operating income?

Albemarle's total operating income in 2024 was -$1.78 billion, based on the following breakdown:

Total Gross Profit: $62.54 million
Total Operating Expenses: $1.84 billion

How has Albemarle revenue changed over the last 9 years?

Over the last 9 years, Albemarle's total revenue changed from $2.83 billion in 2015 to $5.38 billion in 2024, a change of 90.3%.

How much debt does Albemarle have?

Albemarle's total liabilities were at $6.41 billion at the end of 2024, a 25.5% decrease from 2023, and a 3.4% increase since 2015.

How much cash does Albemarle have?

In the past 9 years, Albemarle's cash and equivalents has ranged from $213.73 million in 2015 to $2.27 billion in 2016, and is currently $1.19 billion as of their latest financial filing in 2024.

How has Albemarle's book value per share changed over the last 9 years?

Over the last 9 years, Albemarle's book value per share changed from 29.00 in 2015 to 65.73 in 2024, a change of 126.6%.

Related Companies

This page (NYSE:ALB) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Albemarle (ALB) Financials

Frequently Asked Questions About Albemarle's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Albemarle (ALB) Financials

Annual Income Statements for Albemarle

Quarterly Income Statements for Albemarle

Annual Cash Flow Statements for Albemarle

Quarterly Cash Flow Statements for Albemarle

Annual Balance Sheets for Albemarle

Quarterly Balance Sheets for Albemarle

Annual Metrics And Ratios for Albemarle

Quarterly Metrics And Ratios for Albemarle

Frequently Asked Questions About Albemarle's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools